×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Ovarian Cancer

Feature Video
Dr Shannon Westin, a clinical investigator at the MD Anderson Cancer Center, discusses PARP inhibition for patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.
Maurie Markman, M.D.
The field of ovarian cancer is changing rapidly, and moving toward an era of precision medicine.
Amy Roberts & Janine DeFeo
Jessica Skarzynski
While many advocacy groups set out to raise money for cancer research, a first-of-its-kind charitable crowdfunding platform, called Sound Affects, has set out to change how the war on cancer is fought and financed, all with support from musical talents.
Caroline Seymour
There are now three PARP inhibitors approved for the treatment of ovarian cancer, improving outcomes of many of the women who take them.
Jessica Skarzynski
Paradigms are shifting in the way that ovarian cancer is being treated.
Khevin Barnes
Memorial Day has multiple meanings for this cancer survivor.
Katie Kosko
Survivors teach medical and nursing students around the world about early disease signs and symptoms.
Brielle Urciuoli
Girls Gone Rx sponsors all-female fitness competitions to raise money for Bright Pink, a nonprofit that focuses on prevention and early detection of breast and ovarian cancer.
 
Kristie L. Kahl
Palliative care can be used at all cancer stages, and can drastically improve patients' quality of life.
Kristie L. Kahl
With the number of treatment options consistently increasing, tumor testing is growing more important to personalize care for women with ovarian cancer.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable